NJ State Employees Deferred Compensation Plan’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,000
Closed -$886K 509
2020
Q1
$886K Hold
5,000
0.2% 113
2019
Q4
$956K Hold
5,000
0.16% 130
2019
Q3
$841K Hold
5,000
0.15% 133
2019
Q2
$837K Hold
5,000
0.15% 136
2019
Q1
$732K Buy
+5,000
New +$725K 0.13% 149
2015
Q4
Sell
-5,663
Closed -$1.54M 385
2015
Q3
$1.54M Hold
5,663
0.33% 88
2015
Q2
$1.72M Hold
5,663
0.33% 89
2015
Q1
$1.69M Hold
5,663
0.33% 90
2014
Q4
$1.46M Hold
5,663
0.28% 109
2014
Q3
$1.37M Buy
5,663
+663
+13% +$148K 0.28% 104
2014
Q2
$1.11M Hold
5,000
0.22% 148
2014
Q1
$1.03M Hold
5,000
0.21% 156
2013
Q4
$840K Hold
5,000
0.17% 217
2013
Q3
$720K Hold
5,000
0.16% 245
2013
Q2
$631K Buy
+5,000
New +$566K 0.14% 262

Other funds holding AGN

NJ State Employees Deferred Compensation Plan's AGN Position: Q2 2020 in Review

NJ State Employees Deferred Compensation Plan sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,000 shares — an estimated $886K sold.

NJ State Employees Deferred Compensation Plan first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $1.72M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • NJ State Employees Deferred Compensation Plan reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 5,000 Allergan plc shares in Q2 2020, an estimated $886K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Allergan plc in Q2 2013 and held it in 15 quarters.
  • NJ State Employees Deferred Compensation Plan's Allergan plc position peaked at $1.72M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2020, filed 3 Aug 2020.